Glutathione
Dietary supplementAlso known as: 70-18-8, L-Glutathione reduced, L-Glutathione, Glutathion, Isethion, reduced glutathione, Tathion, Glutinal
Glutathione (70-18-8, L-Glutathione reduced, L-Glutathione) is classified under other / experimental, marketed as a dietary supplement.
Read the full guide: what the research shows on Glutathione →What the research says
Aggregated from the cited literature below. We summarize sources — we don't author claims.
Glutathione (GSH) is referenced across multiple research studies as (i) a biological trigger for disulfide bond cleavage and GSH-responsive assembly/disassembly of peptide-based delivery systems, (ii) a target analyte for peptide-based fluorescent detection/imaging, and (iii) a coupling component (e.g., GSH-modified peptide or GSH-conjugated materials) used in delivery, sensing, or other application-focused systems. (PMIDs: 41419146, 31851512, 31728594, 38477386, 39173226, 31728594, 36252754, 31728594, 31851512, 33235450, 31728594, 36252754, 31728594, 31728594)
Mechanism (as reported)
Across the provided studies, glutathione is used in GSH-responsive designs where elevated intracellular GSH is associated with cleavage of disulfide bonds, leading to disassembly/restructuring and downstream cargo release or functional changes (PMIDs: 41419146, 31851512, 38477386, 31728594, 39173226). In fluorescence sensor studies, GSH is reported to restore fluorescence through binding interactions involving Cu2+ and GSH sulfhydryl groups (PMIDs: 31728594, 38286599).
Key findings (each cites a source)
- A study reported development of a glutathione-responsive self-assembling peptide that coated Salmonella typhimurium and was designed to disassemble via disulfide bond cleavage in a reductive tumor microenvironment with elevated GSH levels, enabling controlled bacterial release at tumor sites. (PMID: 41419146) [PMID 41419146]
- A study reported a reduced glutathione-responsive peptide nanofiber drug delivery system that transformed from three-dimensional micelles into one-dimensional nanofibers, with micelles described as degrading in response to high GSH levels to achieve more release and accumulation of doxorubicin at desired sites. (PMID: 31851512) [PMID 31851512]
- A study reported an injectable chitosan hydrogel system containing a two-dimensional peptide nanosheet-drug conjugate (PNS-SS-DOX) where a disulfide bond was described as responsive to intracellular glutathione (GSH) in tumor cells, enabling controlled drug release and inhibition of cancer cell growth. (PMID: 38477386) [PMID 38477386]
- A study reported a peptide-based fluorescent sensor (FP) designed to bind Cu2+ to trigger fluorescence quenching and described that fluorescence could be restored by GSH due to strong binding between Cu2+ and GSH sulfhydryl groups, enabling imaging of GSH in vitro and in vivo with low toxicity. (PMID: 31728594) [PMID 31728594]
- A study reported a ligand reaction-based fluorescent peptide probe (TGN) for selective detection of Cu2+ and that significant fluorescence recovery occurred after addition of GSH, with the probe described as detecting Cu2+ and GSH concurrently and with reported low biotoxicity and high cell permeability for live cell imaging. (PMID: 38286599) [PMID 38286599]
- A study reported that glutathione in combination with cultivation (seven days of glutathione treatment) was used to induce bioflocculation of Chlorella pyrenoidosa, achieving reported flocculation efficiency after settling and describing changes in nutrient composition and extracellular polymeric substances in flocs compared with control. (PMID: 36252754) [PMID 36252754]
- A study reported coupling structures designed to enhance GSH transdermal absorption using a transdermal enhancer peptide (TD1), with results including reported melanin synthesis inhibition in cell models and reduced pigmentation in guinea pig and zebrafish pigmentation models, and reported transdermal penetration measurements using electric two-photon microscopy. (PMID: 39173226) [PMID 39173226]
- A study reported synthesis of linalool-loaded gold nanoparticles capped with glutathione and conjugated with a CALNN peptide, and investigated apoptosis-related effects in SKOV-3 cells, reporting antiproliferative effects and described apoptosis induction with associated markers/pathways in the experimental context. (PMID: 33235450) [PMID 33235450]
Independent HPLC purity tests (88)
Real third-party HPLC results aggregated from Peptigrity, each attributed to the lab that ran it — average purity 99.6% across 88 tests. Not our verdict.
Labs: ILS Laboratories, Vanguard Laboratory, Bioviridian, freedomdiagnosticstesting.com, Janoshik Labs, Kovera Labs, BTLabs, Chromate.
| Vendor | HPLC purity | Lab | Date |
|---|---|---|---|
| ezpeps.com | 99.29% | ILS Laboratories | 2026-07-09 |
| onedaycompounds.com | 99.80% | Vanguard Laboratory | 2026-07-06 |
| Humatide Peptides | 99.71% | ILS Laboratories | 2026-06-27 |
| americanpeptides.us | 99.90% | Bioviridian | 2026-06-17 |
| nationalsciencelabs.co | 99.67% | freedomdiagnosticstesting.com |
Research literature (9)
Consolidated from PubMed — each links to the original record.
- Glutathione-responsive self-assembling peptide-coated Salmonella for antitumor therapy.
Shen J, Zhu Y, Li T, Wu X, Zheng JH, Shi J · Journal of controlled release : official journal of the Controlled Release Society · 2026 · PMID 41419146
- A PEDF-Derived Short Peptide Prevents Sodium Iodate-Induced Retinal Degeneration in Rats by Activating the SLC7A11/GSH/GPX4 Pathway in the RPE Cells.
Ho TC, Tsai SH, Yeh SI, Sun MH, Tsao YP · Journal of cellular and molecular medicine · 2025 · PMID 40703032
- Ligand reaction-based fluorescent peptide probes for the detection of Cu(2+) and glutathione.
Zhou J, Hao J, Wang D, Wu J, Wang Z, Lin P · Luminescence : the journal of biological and chemical luminescence · 2024 · PMID 38286599
- Improved efficacy of linear glutathione-peptide chaperon complexes on melanogenesis inhibition and transdermal delivery.
Zheng J, Ma Q, Haider A, Liu S, Jia Y, Zhang J · Bioorganic chemistry · 2024 · PMID 39173226
- Injectable Chitosan Hydrogels Doped with 2D Peptide Nanosheet-Drug Conjugates for Glutathione-Responsive Sustained Drug Delivery.
Luan X, Hu H, Zhu D, He P, Sun Z, Xi Y · Chemistry (Weinheim an der Bergstrasse, Germany) · 2024 · PMID 38477386
- Small peptide glutathione-induced bioflocculation for enhancing the food application potential of Chlorella pyrenoidosa.
Hao N, Liu Z, Hou Y, Fan Z, Li Y, Chen F · Bioresource technology · 2022 · PMID 36252754
FAQ
- What is Glutathione?
- Glutathione (70-18-8, L-Glutathione reduced, L-Glutathione) is classified under other / experimental, marketed as a dietary supplement. Research goals associated with it include longevity & cellular aging.
- Is Glutathione FDA-approved?
- Glutathione is marketed as a dietary supplement, not an FDA-approved drug.
- What does the research on Glutathione say?
- peptideone aggregates 9 references from PubMed for Glutathione. The summary on this page digests them with citations; we summarize sources and make no efficacy claims.